Join
Live feed
·
INSIDERFilingvia Quantisnow
Bristol-Myers Squibb Company logo

President, Cell Therapy Org. Hoch Lynelle converted options into 8,192 shares, disposed of 3,302 shares and covered exercise/tax liability with 1,391 shares, increasing direct ownership by 74% to 8,210 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
BMY· Bristol-Myers Squibb Company
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BMY (Bristol-Myers Squibb Company) and more on Quantisnow.

President, Cell Therapy Org. Hoch Lynelle converted options into 8,192 shares, disposed of 3,302 shares and covered exercise/tax liability with 1,391 shares, increasing direct ownership by 74% to 8,210 units (SEC Form 4) | Quantisnow